Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Journal of Natural Products|November 14, 2014
Borrelidin B: isolation, biological activity, and implications for nitrile biosynthesisChristopher J Schulze, Walter M Bray, Frank Loganzo, et al.Biomarkers in Medicine|May 19, 2010
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxicsGrant Sellar, John D Alvarez, Frank Loganzo, et al.Bioorganic & Medicinal Chemistry Letters|January 19, 2019
Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activityDahui Zhou, Jeffrey Casavant, Edmund I Graziani, et al.Molecular Cancer Therapeutics|March 1, 2006
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubulesMalathi Hari, Frank Loganzo, Tami Annable, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 10, 2018
Establishing in vitro-in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approachDhaval K Shah, Frank Loganzo, Nahor Haddish-Berhane, et al.Journal of Natural Products|August 8, 2014
Cytotoxic Spliceostatins from Burkholderia sp. and Their Semisynthetic AnaloguesHaiyin He, Anokha S Ratnayake, Jeffrey E Janso, et al.Bioorganic & Medicinal Chemistry|April 10, 2007
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2Allan Wissner, Heidi L Fraser, Charles L Ingalls, et al.Journal of the American Chemical Society|October 28, 2014
Synthesis, molecular editing, and biological assessment of the potent cytotoxin leiodermatolideDamien Mailhol, Jens Willwacher, Nina Kausch-Busies, et al.Pharmaceutical Biology|February 2, 2011
Depsides isolated from the Sri Lankan lichen Parmotrema sp. exhibit selective Plk1 inhibitory activityDavid E Williams, Frank Loganzo, Lauren Whitney, et al.Molecular Cancer Therapeutics|October 14, 2003
MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivoDeepak Sampath, Carolyn M Discafani, Frank Loganzo, et al.Pageof 5